West Coast University's Hybrid PharmD Program
Supplied by an entity that has paid the news provider for its placement; not impartial journalism.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
West Coast University's hybrid Doctor of Pharmacy (PharmD) program is designed to meet the needs of modern students while addressing the demands of the rapidly changing pharmacy profession.
What sets WCU apart? It starts with an accelerated hybrid curriculum—one of the first of its kind in the nation. Unlike traditional programs that can take up to four years, WCU's PharmD program condenses the journey into 33 months, allowing students to make an impact on patient care sooner. This streamlined approach blends the flexibility of online learning with essential, hands-on clinical practice.
Located in the heart of Los Angeles, the Center for Graduate Studies offers students access to powerful, science-backed learning tools. The campus is equipped with interactive learning environments and immersive technology designed for experiential learning.
Each trimester, students spend one intensive week on the CGS campus, honing their clinical skills in an environment that mirrors real-world settings. Here, students don't just learn pharmacy—they experience it.
One of the standout features of WCU's PharmD program is its use of a virtual pharmacy. This immersive tool allows students to practice medication dispensing, patient counseling and even pharmacy operations in a highly realistic setting. By the time they step into a live pharmacy environment, WCU students have learned the skills to be confident, experienced and prepared to excel.
To further bolster their preparedness, PharmD students benefit from comprehensive study resources and one-on-one exam preparation throughout their program, helping them feel confident as they sit for the North American Pharmacist Licensure Examination (NAPLEX).
But the WCU PharmD experience is much deeper than just academics. Students are actively involved in community outreach, participating in wellness fairs, immunization clinics and other patient-centered health care events. These real-world opportunities allow students to apply their knowledge while making an impact on the community. The sense of fulfillment students gain from these experiences is invaluable as they build a connection with the community they serve. From easily accessible faculty to dedicated support services, WCU provides students with access to everything they need to succeed, both academically and professionally. Whether it's one-on-one mentoring or career guidance, WCU supports students at every step of their journey.
Take it from Janna M., a current PharmD student: "The combination of an accelerated timeline and the flexibility of hybrid learning has been a game-changer for me. I get the support I need, and I'm on track to achieve my dream of becoming a pharmacist faster than I ever thought possible."
Read all about Janna's inspiring story here.
Graduates of WCU's hybrid PharmD program are not just prepared to enter the workforce—they're poised to lead it. Choosing to enroll in this accelerated doctoral program, which can be completed nearly a year sooner than traditional programs, reflects the seriousness with which WCU pharmacy students approach their careers and their readiness to take on leadership roles.
Whether working in a hospital, a community pharmacy or a research facility, WCU's hybrid PharmD program helps empower students to make a difference. Join a community of passionate learners and dedicated professionals who are shaping the future of pharmacy.
Ready to take the next step? Learn how joining an accelerated program can help you achieve your career goals sooner. Schedule an information session today!
WCU provides career guidance and assistance but cannot guarantee employment. The opinion is the individual's sole opinion and not necessarily representative of that of the school, any instructor or any other student.
This article has been paid for by a third party. The views and opinions expressed are not those of Newsweek and are not an endorsement of the products, services or persons mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
2 hours ago
- Newsweek
Mushroom Recall Sparks Nationwide Warning to Customers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Hofood99 Inc. is recalling packages of their Enoki Mushrooms due to fears the product may be contaminated with listeria. Newsweek reached out to the company via phone for additional comment on Wednesday and left a voicemail. Why It Matters Numerous recalls have been initiated this year due to the potential for the following: damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or food allergies every year. According to the Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. The FDA warns that Listeria monocytogenes is an organism that could cause serious and sometimes fatal infections in frail or older people, young children and those with weakened immune systems. Listeria could also lead to stillbirths or miscarriages in pregnant women, the FDA says. What To Know According to the FDA alert, the mushrooms were distributed nationwide to stores and retailers. The recalled mushrooms are sold in 200-gram green plastic packaging with a with UPC Barcode of 6 976532 310051 seen on the back label. No illnesses or injuries have been reported related to the recalled mushrooms. The mushrooms were distributed by Hofood99 Inc., located at 21903 56th Avenue Oakland Gardens, New York 11364. Recalled packages of Enoki Mushroom from Hofood99 Inc. can be seen in a June 11, 2025, recall alert. (Photo from the U.S. Food and Drug Administration) Recalled packages of Enoki Mushroom from Hofood99 Inc. can be seen in a June 11, 2025, recall alert. (Photo from the U.S. Food and Drug Administration) What People Are Saying The FDA in the alert in part: "The contamination was discovered after samples were collected from a store in Michigan and subsequent analysis by Michigan Department of Agriculture & Rural Development (MDARD) Laboratory Division revealed the presence of Listeria monocytogenes." In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall, the FDA shares that release on our website as a public service. "The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall," the FDA continued. It added: "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled." Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts. What Happens Next Customers who have purchased the recalled mushrooms may return the product to the original place of purchase for a full refund or destroy it, the FDA says. People with additional questions may contact the company at (917) 756-9833 weekdays from 9 a.m. to 2 p.m.
Newsweek
5 hours ago
- Newsweek
Best Specialized Hospitals Asia Pacific 2025
Best Specialized Hospitals Asia Pacific 2025 Is your hospital not featured in the ranking? Discover the new Global Hospital Rating by Newsweek and Statista.
Newsweek
6 hours ago
- Newsweek
Map Shows States With the Worst Hospital Ratings
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. New data has revealed the states where hospital care is the worst ranked by patients. The study, led from the University of Utah, analyzed 3,286 hospitals across the country, using data from the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey, which ran from July 1, 2021 to June 30, 2022. Patients were asked to rate ten specific aspects of their hospital stay, including how they felt about communication with doctors and nurses, how clean their rooms were, and whether they received adequate information upon discharge. States were given an average rating on a five-point scale, with five stars being the highest possible score. New York and South Carolina were rated the poorest—in New York, patients rated doctor communication and cleanliness a two, with all other rankings receiving a one; while South Carolina received a two on all rankings except for cleanliness, which received a one. South Dakota was the only state to receive a five-star rating, getting fives across the board apart except for "communications about medicines" and "care transition", which were both rated at four stars. While not displayed in the above map, Washington, D.C. and Puerto Rico also recieved poor rankings, particularly in critical areas such as staff responsiveness and discharge information to patients. According to the researchers, the Midwest was the region with the most satisfied patients on average, with high scores around staff communication and hospital cleanliness in particular. As the study was conducted on patient reviews during the COVID-19 pandemic and associated restrictions, it noted that the healthcare issues may have changed or improved in the years since. However, the findings may still guide policymakers in efforts to emulate the outcomes of the highest-performing regions. "While one might expect no significant differences in patient satisfaction among hospitalized patients across the U.S., our findings revealed small but statistically significant regional variations," the team said in a statement. They added that disparities between states may indicate a need for policy reform or increased investment—such as funding hospital improvements or staff training initiatives. "These variations could also reflect unequal access to healthcare or differences in care quality among diverse populations." Despite this, the team noted that overall satisfaction and willingness to recommend a given hospital were "consistently rated moderately high" across the U.S., but "satisfaction scores were lowest for communication about medications and discharge information." Do you have a tip on a science story that Newsweek should be covering? Do you have a question about health care? Let us know via science@ Reference Hung, M., Vu, S., Hon, E. S., Reese, L., Gardner, J., & Lipsky, M. S. (2025). Unveiling the drivers of patient satisfaction in the United States hospitals: Assessing quality indicators across regions. PLOS ONE, 20(6).
